Literature DB >> 30445188

Comparison Study of Laparoscopic Sentinel Lymph Node Mapping in Endometrial Carcinoma Using Carbon Nanoparticles and Lymphatic Pathway Verification.

Jing Zuo1, Ling Ying Wu1, Min Cheng1, Ping Bai1, Cheng Zhi Lei1, Ning Li1, Gong Yi Zhang1, Dan Zhao1, Bin Li2.   

Abstract

STUDY
OBJECTIVE: To evaluate the detection rate and accuracy of sentinel lymph node (SLN) mapping using cervical and fundal injections of carbon nanoparticles (CNPs) in laparoscopic surgery of endometrioid endometrial cancer (EC) and to identify uterine lymphatic drainage pathways validated by mapping.
DESIGN: A prospective consecutive study (Canadian Task Force classification II-2).
SETTING: An academic research center. PATIENTS: Consecutive patients with a pathologic diagnosis of early-stage EC scheduled for primary laparoscopic-assisted staging surgery (laparoscopic hysterectomy, bilateral salpingo-oophorectomy, or comprehensive lymphadenectomy).
INTERVENTIONS: Enrolled patients underwent laparoscopic SLN mapping with a 50-mg CNP tracer injection. Fifty patients received fundal subserosal injections at 4 sites (the fundal group), whereas 65 patients received cervical submucosal injections at 2 sites (the cervical group). After SLN mapping, all patients underwent laparoscopic staging surgery.
MEASUREMENTS AND MAIN RESULTS: No allergic reactions to CNPs were observed in either group. The overall SLN detection rates were 100% and 92% in the cervical and fundal groups, and the bilateral SLN detection rates were 97% and 68% (p < .001), respectively. A total of 12 metastatic SLNs were accurately detected in 5 patients. The sensitivity of metastatic lymph node detection was 100% in the cervical group, which is higher than that in the fundal group (80%). The false-negative rates were 0% and 20%, respectively, in the cervical and fundal groups. Furthermore, we verified 3 uterine lymphatic pathways using the 2 injection methods. The upper paracervical pathway was the most common drainage pathway in both groups (91.4% in the cervical group vs 80.24% in the fundal group), whereas the infundibulopelvic pathway was observed only in the fundal group (15.11%).
CONCLUSION: SLN mapping by CNPs in laparoscopic surgery for EC is a safe and effective alternative, with a higher detection rate and better accuracy with cervical injections than fundal injections. The upper paracervical pathway was the most common lymphatic pathway, whereas the infundibulopelvic pathway was only displayed in fundal injections.
Copyright © 2018 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carbon nanoparticles; Endometrioid endometrial cancer; Lymphatic pathway; Sentinel lymph node

Mesh:

Substances:

Year:  2018        PMID: 30445188     DOI: 10.1016/j.jmig.2018.11.002

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  5 in total

Review 1.  Current and novel mapping substances in gynecologic cancer care.

Authors:  Lea A Moukarzel; Jacqueline Feinberg; Evan J Levy; Mario M Leitao
Journal:  Int J Gynecol Cancer       Date:  2020-01-17       Impact factor: 3.437

2.  Status of Sentinel Lymph Node Biopsy in Endometrial Cancer.

Authors:  Florin Andrei Taran; Lisa Jung; Julia Waldschmidt; Sarah Isabelle Huwer; Ingolf Juhasz-Böss
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-05-20       Impact factor: 2.915

Review 3.  The Application of Carbon Nanomaterials in Sensing, Imaging, Drug Delivery and Therapy for Gynecologic Cancers: An Overview.

Authors:  Changji Xiao; Changming Li; Jun Hu; Lirong Zhu
Journal:  Molecules       Date:  2022-07-13       Impact factor: 4.927

Review 4.  Sentinel Lymph Node Mapping in Endometrial Cancer: A Comprehensive Review.

Authors:  Lirong Zhai; Xiwen Zhang; Manhua Cui; Jianliu Wang
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

5.  Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.

Authors:  Hans Nagar; Nina Wietek; Richard J Goodall; Will Hughes; Mia Schmidt-Hansen; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2021-06-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.